Stockscreener 앱 받기
1.25
0.79%
-0.01
시간 외 거래:
1.24
-0.01
-0.80%
전일 마감가:
$1.26
열려 있는:
$1.23
하루 거래량:
545.60K
Relative Volume:
0.12
시가총액:
$51.36M
수익:
-
순이익/손실:
$-21.02M
주가수익비율:
-1.9952
EPS:
-0.6265
순현금흐름:
$-14.59M
1주 성능:
-14.97%
1개월 성능:
-14.97%
6개월 성능:
-26.04%
1년 성능:
-37.66%
1일 변동 폭
$1.2104
$1.29
1주일 범위
$1.2104
$1.44
52주 변동 폭
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.25 | 51.77M | 0 | -21.02M | -14.59M | -0.6265 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.29B | 191.83M | 362.67M | 2.182 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-16 | 다운그레이드 | The Benchmark Company | Buy → Speculative Buy |
| 2025-12-11 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | 개시 | H.C. Wainwright | Buy |
| 2025-10-31 | 개시 | Roth Capital | Buy |
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today
Aug Catalysts: Is HeartBeam Inc Equity Warrant benefiting from interest rate changesMarket Activity Report & Community Trade Idea Sharing - baoquankhu1.vn
Trend Recap: Is HeartBeam Inc a turnaround storyWeekly Trade Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
H.C. Wainwright reiterates Heartbeam stock rating on commercial progress By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Heartbeam stock rating on commercial progress - Investing.com
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam Shares Fall After Benchmark Maintains Speculative Buy Rating - marketscreener.com
Benchmark Maintains HeartBeam's Rating at Speculative Buy, Price Target is $8 - marketscreener.com
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam Shares Fall After Benchmark Downgrade - marketscreener.com
HeartBeam partners with Mount Sinai to advance AI-powered ECG technology - MSN
Benchmark Downgrades HeartBeam to Speculative Buy From Buy, Price Target is $8 - marketscreener.com
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - USA Today
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript - AOL.com
HeartBeam to present at March investor conferences By Investing.com - Investing.com Nigeria
HeartBeam reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
HeartBeam Earnings Call Balances Breakthroughs With Cash Risk - TipRanks
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch By Investing.com - Investing.com Australia
HeartBeam (NASDAQ: BEAT) files $100M shelf; $78.8M previously registered unsold - Stock Titan
HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - NewMediaWire
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript - Insider Monkey
HeartBeam, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Precision Neuroscience, founded by Neuralink alums, is developing a competing brain implant that it says is safer - AOL.com
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch - Investing.com India
Earnings call transcript: HeartBeam Q4 2025 misses EPS, stock rises - Investing.com Nigeria
HeartBeam Q4 2025 Earnings Call Transcript - MarketBeat
HeartBeam, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-03-12 - Seeking Alpha
HeartBeam : Investor Presentation – March 2026 - marketscreener.com
HeartBeam : Fourth Quarter 2025 Earnings Conference Call Presentation - marketscreener.com
HeartBeam Q4 net loss widens - TradingView
BEAT: FDA-cleared at-home ECG, new partnerships, and improved cash position drive growth - TradingView
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
HeartBeam Reports Fourth Quarter and Full Year 2025 Results - The Chronicle-Journal
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences - USA Today
Panic Selling: Can HeartBeam Inc outperform in the next rally2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
HeartBeam announces first commercial customer as ClearCardio brings groundbreaking 12-lead ECG technology to high-growth preventive cardiology market - MSN
HeartBeam partners with Mount Sinai on AI-ECG development By Investing.com - Investing.com Canada
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai - Bitget
HeartBeam advances portable cardiac monitoring platform after FDA clearance - DOTmed
HeartBeam announces first patient enrollments in heart attack detection pilot study - MSN
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study - Stocktwits
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home - Stocktwits
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Stocktwits
After Hours: HeartBeam (BEAT) NASDAQ $1.35 (-8.78%) pre-Mar 12 earnings: watch guidance - Meyka
HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - NewMediaWire
Heartbeam Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
자본화:
|
볼륨(24시간):